Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Gyre Therapeutics (GYRE) Times Interest Earned: 2009-2024

Historic Times Interest Earned for Gyre Therapeutics (GYRE) over the last 6 years, with Mar 2024 value amounting to $25.62.

  • Gyre Therapeutics' Times Interest Earned rose 147.23% to $25.62 in Q1 2024 from the same period last year, while for Mar 2024 it was -$63.54, marking a year-over-year decrease of 254.43%. This contributed to the annual value of -$25.92 for FY2023, which is 486.95% down from last year.
  • Per Gyre Therapeutics' latest filing, its Times Interest Earned stood at $25.62 for Q1 2024, which was up 147.23% from $10.36 recorded in Q1 2023.
  • Gyre Therapeutics' 5-year Times Interest Earned high stood at $25.62 for Q1 2024, and its period low was -$2,300 during Q3 2020.
  • Moreover, its 2-year median value for Times Interest Earned was $17.99 (2024), whereas its average is $17.99.
  • Data for Gyre Therapeutics' Times Interest Earned shows a peak YoY surged of 147.23% (in 2024) over the last 5 years.
  • Over the past 3 years, Gyre Therapeutics' Times Interest Earned (Quarterly) stood at -$265.37 in 2020, then reached $10.36 in 2023, then soared by 147.23% to $25.62 in 2024.
  • Its last three reported values are $25.62 in Q1 2024, $10.36 for Q1 2023, and -$265.37 during Q4 2020.